Mei-Shi Subsidiary Lotus Pharma Bulgaria EOOD Announces Fund Lending to Parent Company

1. Factual Date: 115/06/18

2. Recipient of Fund Lending: (1) Company Name: Lotus International Pte. Ltd. (2) Relationship with Lending Party: Parent Company (3) Lending Limit (in thousand TWD): 2,899,354 (4) Previous Outstanding Balance (in thousand TWD): 2,042,151 (5) Amount of New Lending (in thousand TWD): 663,075 (6) Is this a board-authorized revolving or multiple disbursement arrangement by the chairman to the same party?: No (7) Outstanding Lending Balance as of Factual Date (in thousand TWD): 2,705,226 (8) Reason for New Lending: Required for daily operational working capital.

3. Collateral Provided by Recipient: (1) Description: None (2) Value (in thousand TWD): 0

4. Latest Financial Statement of Recipient: (1) Capital (in thousand TWD): 1,580,213 (2) Accumulated Deficit (in thousand TWD): -51,663

5. Interest Calculation Method: 3-month SOFR reference rate plus 1.3%.

6. Repayment Terms: (1) Conditions: As stipulated in the contract. (2) Date: Five-year term starting from the first disbursement date.

7. Total Outstanding Lending Balance as of Factual Date (in thousand TWD): 77,264,028

8. Ratio of Total Lending Balance to the Net Equity of the Publicly Listed Company (Latest Financial Statement): 321.50%

9. Source of Lending Funds: The subsidiary itself

10. Other Disclosures: The amount of this fund lending is USD 21 million, converted at the Taiwan Bank exchange rate on June 17, 115 (1 USD = 31.575 TWD).